199 related articles for article (PubMed ID: 29975467)
21. Differentiation of brain infection from necrotic glioblastoma using combined analysis of diffusion and perfusion MRI.
Chawla S; Wang S; Mohan S; Nasrallah M; Verma G; Brem S; O'Rourke DM; Wolf RL; Poptani H; Nabavizadeh SA
J Magn Reson Imaging; 2019 Jan; 49(1):184-194. PubMed ID: 29676844
[TBL] [Abstract][Full Text] [Related]
22. CT, conventional, and functional MRI features of skull lymphoma: a series of eight cases in a single institution.
Xing Z; Huang H; Xiao Z; Yang X; Lin Y; Cao D
Skeletal Radiol; 2019 Jun; 48(6):897-905. PubMed ID: 30310943
[TBL] [Abstract][Full Text] [Related]
23. Differentiating Between Primary Central Nervous System Lymphomas and Glioblastomas: Combined Use of Perfusion-Weighted and Diffusion-Weighted Magnetic Resonance Imaging.
Makino K; Hirai T; Nakamura H; Kuroda JI; Shinojima N; Uetani H; Kitajima M; Yano S
World Neurosurg; 2018 Apr; 112():e1-e6. PubMed ID: 29104150
[TBL] [Abstract][Full Text] [Related]
24. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
Saini J; Kumar Gupta P; Awasthi A; Pandey CM; Singh A; Patir R; Ahlawat S; Sadashiva N; Mahadevan A; Kumar Gupta R
Clin Radiol; 2018 Nov; 73(11):986.e7-986.e15. PubMed ID: 30197047
[TBL] [Abstract][Full Text] [Related]
25. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors.
Rollin N; Guyotat J; Streichenberger N; Honnorat J; Tran Minh VA; Cotton F
Neuroradiology; 2006 Mar; 48(3):150-9. PubMed ID: 16470375
[TBL] [Abstract][Full Text] [Related]
26. Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.
Kong Z; Yan C; Zhu R; Wang J; Wang Y; Wang Y; Wang R; Feng F; Ma W
Neuroimage Clin; 2018; 20():51-60. PubMed ID: 30069427
[TBL] [Abstract][Full Text] [Related]
27. Adding DSC PWI and DWI to BT-RADS can help identify postoperative recurrence in patients with high-grade gliomas.
Yang Y; Yang Y; Wu X; Pan Y; Zhou D; Zhang H; Chen Y; Zhao J; Mo Z; Huang B
J Neurooncol; 2020 Jan; 146(2):363-371. PubMed ID: 31902040
[TBL] [Abstract][Full Text] [Related]
28. Astrocytic tumour grading: a comparative study of three-dimensional pseudocontinuous arterial spin labelling, dynamic susceptibility contrast-enhanced perfusion-weighted imaging, and diffusion-weighted imaging.
Xiao HF; Chen ZY; Lou X; Wang YL; Gui QP; Wang Y; Shi KN; Zhou ZY; Zheng DD; Wang DJ; Ma L
Eur Radiol; 2015 Dec; 25(12):3423-30. PubMed ID: 26002128
[TBL] [Abstract][Full Text] [Related]
29. Probabilistic independent component analysis of dynamic susceptibility contrast perfusion MRI in metastatic brain tumors.
Chakhoyan A; Raymond C; Chen J; Goldman J; Yao J; Kaprealian TB; Pouratian N; Ellingson BM
Cancer Imaging; 2019 Mar; 19(1):14. PubMed ID: 30885275
[TBL] [Abstract][Full Text] [Related]
30. New MR perfusion features in primary central nervous system lymphomas: pattern and prognostic impact.
Blasel S; Vorwerk R; Kiyose M; Mittelbronn M; Brunnberg U; Ackermann H; Voss M; Harter PN; Hattingen E
J Neurol; 2018 Mar; 265(3):647-658. PubMed ID: 29383512
[TBL] [Abstract][Full Text] [Related]
31. Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.
Di Costanzo A; Trojsi F; Giannatempo GM; Vuolo L; Popolizio T; Catapano D; Bonavita S; d'Angelo VA; Tedeschi G; Scarabino T
J Exp Clin Cancer Res; 2006 Sep; 25(3):383-90. PubMed ID: 17167979
[TBL] [Abstract][Full Text] [Related]
32. Differentiating glioblastoma from primary central nervous system lymphoma of atypical manifestation using multiparametric magnetic resonance imaging: A comparative study.
Feng A; Li L; Huang T; Li S; He N; Huang L; Zeng M; Lyu J
Heliyon; 2023 Apr; 9(4):e15150. PubMed ID: 37095995
[TBL] [Abstract][Full Text] [Related]
33. Correlation between dynamic susceptibility contrast perfusion MRI and genomic alterations in glioblastoma.
Ozturk K; Soylu E; Cayci Z
Neuroradiology; 2021 Nov; 63(11):1801-1810. PubMed ID: 33738509
[TBL] [Abstract][Full Text] [Related]
34. Prominent hypointense veins on susceptibility weighted image in the cat brain with acute infarction: DWI, SWI, and PWI.
Kim YW; Kim HJ; Choi SH; Kim DC
Acta Radiol; 2014 Oct; 55(8):1008-14. PubMed ID: 24136983
[TBL] [Abstract][Full Text] [Related]
35. Diffusion- and perfusion-weighted MR imaging in persistent migrainous visual disturbances.
Jäger HR; Giffin NJ; Goadsby PJ
Cephalalgia; 2005 May; 25(5):323-32. PubMed ID: 15839846
[TBL] [Abstract][Full Text] [Related]
36. Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.
Di Costanzo A; Scarabino T; Trojsi F; Giannatempo GM; Popolizio T; Catapano D; Bonavita S; Maggialetti N; Tosetti M; Salvolini U; d'Angelo VA; Tedeschi G
Neuroradiology; 2006 Sep; 48(9):622-31. PubMed ID: 16752135
[TBL] [Abstract][Full Text] [Related]
37. Percentage signal intensity recovery: A step ahead of rCBV in DSC MR perfusion imaging for the differentiation of common neoplasms of brain.
Surendra KL; Patwari S; Agrawal S; Chadaga H; Nagadi A
Indian J Cancer; 2020; 57(1):36-43. PubMed ID: 31898591
[TBL] [Abstract][Full Text] [Related]
38. Comparison of unsupervised classification methods for brain tumor segmentation using multi-parametric MRI.
Sauwen N; Acou M; Van Cauter S; Sima DM; Veraart J; Maes F; Himmelreich U; Achten E; Van Huffel S
Neuroimage Clin; 2016; 12():753-764. PubMed ID: 27812502
[TBL] [Abstract][Full Text] [Related]
39. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
[TBL] [Abstract][Full Text] [Related]
40. Application of diffusion-weighted imaging and dynamic susceptibility contrast perfusion-weighted imaging for ganglioglioma in adults: Comparison study with oligodendroglioma.
Lee S; Yun TJ; Kang KM; Rhim JH; Park CK; Kim TM; Park SH; Kim IH; Choi SH
J Neuroradiol; 2016 Oct; 43(5):331-8. PubMed ID: 27502573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
